Nos tomamos el tiempo necesario para comprender sus problemas especficos y asegurarnos de que el tratamiento se ajusta a sus necesidades generales de salud y a su plan de control de peso a largo plazo
In 2021, the FDA approved Wegovy (a higher-dose version of semaglutide) for chronic weight management in people with obesity
Due to its broad mechanism of action, retatrutide is frequently considered a next-generation GLP-based research compound and a leading focus in modern metabolic studies
Neither type of compounded formulation undergoes FDA approval for safety and efficacy the way brand-name drugs do
The post says worsening nausea, vomiting, or constipation as the dose rises suggests a ceiling has been reached, and that a slower pace or an alternative formulation may be warranted at that point
If youre on Wegovy 2.4 mg and losing weight well, switching to Ozempic 2 mg means accepting a lower dose